Gruber F, Kastelan M, Cabrijan L, Simonić E, Brajac I
Department of Dermatology, Clinical Hospital Center, Medical School, Rijeka, Croatia.
J Chemother. 2000 Jun;12(3):240-3. doi: 10.1179/joc.2000.12.3.240.
An open, noncomparative study was performed to establish the efficacy of azithromycin in the treatment of early syphilis. Sixteen patients were treated with oral azithromycin: 1g the first day and then 500 mg for the following 8 days. Two patients were excluded from the study, leaving 14 patients for the evaluation of the efficacy. Venereal Disease Research Laboratory (VDRL) negativity was observed in 3 out of 6 patients treated for primary syphilis after 3 months and in all patients after 6 months. Two of 8 patients treated for manifest or early latent secondary syphilis had VDRL negativity after 3 months and 4 patients after 6 months. This study demonstrates that azithromycin is effective in the treatment of early syphilis. Two patients experienced gastrointestinal side effects which did not require treatment interruption.
进行了一项开放性、非对照研究,以确定阿奇霉素治疗早期梅毒的疗效。16例患者接受口服阿奇霉素治疗:第1天服用1g,随后8天每天服用500mg。2例患者被排除在研究之外,剩余14例患者进行疗效评估。6例一期梅毒患者中,3例在治疗3个月后梅毒血清学试验(VDRL)转阴,6个月后所有患者VDRL转阴。8例显性或早期潜伏性二期梅毒患者中,2例在治疗3个月后VDRL转阴,4例在6个月后VDRL转阴。本研究表明,阿奇霉素治疗早期梅毒有效。2例患者出现胃肠道副作用,但无需中断治疗。